Allakos Inc
San Carlos, US · Founded 2012 · Delaware corporation · 6 known investors
Find your way into Allakos Inc
Sign up to see every warm intro you have to Allakos Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allakos Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.
Founders & leadership
Allakos Inc was founded in 2012 by Nenad Tomasevic and Christopher Bebbington.
Board


Investors · 6
How we know: Alta Partners's portfolio page · board seat on SEC Form D · funding news · prnewswire.com · Not right? Tell us
How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RiverVest Venture Partners's portfolio page · a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
How we know: Samsara BioCapital's portfolio page · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$128.1M disclosed across 2 of 3 rounds · 2012–2017
- Undisclosed amountSeries A ExtensionSep 2014
Alta Partners, Novo Ventures, RiverVest Venture Partners, Roche Venture Fund
Source ↗
▶$100.1MraisedDec 2017 · 40 investors · BiotechnologyRule 506(b)
- Dan JanneyDirector
- John McKearnDirector
- Robert AlexanderExecutive Officer, Director
- Adam TomasiExecutive Officer
- Steve JamesDirector
- Paul WalkerDirector
- Offering amount
- $100.1M
- Amount sold
- $100.1M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.9MraisedMar 2015 · 12 investors · PharmaceuticalsRule 506(b)
- Nenad TomasevicExecutive Officer
- Farah ChampsiDirector
- Alejandro DorenbaumExecutive Officer
- John McKearnDirector
- Peter MoldtDirector
- Christopher BebbingtonExecutive Officer, Director
- Offering amount
- $47M
- Amount sold
- $27.9M
- First sale
- Dec 2012
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Allakos Inc do?
- Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.
- Who founded Allakos Inc?
- Allakos Inc was founded by Nenad Tomasevic, Christopher Bebbington in 2012.
- Who are Allakos Inc's investors?
- Allakos Inc's investors include Alta Partners, LifeSci Venture Partners, New Enterprise Associates (NEA), RiverVest Venture Partners, Samsara BioCapital, Roche Venture Fund.
- How much funding has Allakos Inc raised?
- Allakos Inc has disclosed $128.1M raised across 2 of its 3 known rounds.
- Where is Allakos Inc headquartered?
- Allakos Inc is headquartered in San Carlos, US.

